# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-15-2024 | 03-31-2024 | 10-Q | |
2 | 04-01-2024 | 12-31-2023 | 10-K | |
3 | 10-27-2023 | 09-30-2023 | 10-Q | |
4 | 07-28-2023 | 06-30-2023 | 10-Q | |
5 | 05-10-2023 | 03-31-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...
MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testoste...